SPONSOR
Beneficência Portuguesa de São Paulo
Total Trials
2
Recruiting
2
Phases
Phase 4
Beneficência Portuguesa de São Paulo is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Breast Neoplasm Female, Quality of Life, Febrile Neutropenia.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beneficência Portuguesa de São Paulo
How many clinical trials has Beneficência Portuguesa de São Paulo sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Beneficência Portuguesa de São Paulo, of which 2 are actively recruiting participants. These trials cover conditions including Breast Neoplasm Female, Quality of Life, Febrile Neutropenia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beneficência Portuguesa de São Paulo research focus on?
Beneficência Portuguesa de São Paulo clinical trials span Breast Neoplasm Female, Quality of Life, Febrile Neutropenia. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Beneficência Portuguesa de São Paulo clinical trial?
To participate in a Beneficência Portuguesa de São Paulo trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beneficência Portuguesa de São Paulo trials with current recruitment status updated daily.
Clinical Trials by Beneficência Portuguesa de São Paulo
NCT05277935
Recruiting
Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib
Breast Neoplasm Female
NCT06342115 Phase 4
Recruiting
Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens
Febrile Neutropenia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology